Sbi Securities Co., Ltd. Regulus Therapeutics Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,183 shares of RGLS stock, worth $9,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,183
Previous 412
187.14%
Holding current value
$9,333
Previous $651,000
217.97%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RGLS
# of Institutions
79Shares Held
53.7MCall Options Held
104KPut Options Held
4.1K-
Federated Hermes, Inc. Pittsburgh, PA15.8MShares$125 Million0.06% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$51 Million1.07% of portfolio
-
Octagon Capital Advisors LP New York, NY4.64MShares$36.6 Million2.7% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$31.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$31.2 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $115M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...